New cancer research shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.
New vulnerability found in lung squamous cancer may facilitate drug targeting
New cancer research shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.